Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination
- PMID: 33852795
- PMCID: PMC8063883
- DOI: 10.1056/NEJMc2105869
Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination
Comment in
-
Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination - Response from the Manufacturer.N Engl J Med. 2021 May 20;384(20):1965-1966. doi: 10.1056/NEJMc2106075. Epub 2021 Apr 16. N Engl J Med. 2021. PMID: 33861522 Free PMC article. No abstract available.
Similar articles
-
Vaccine-induced thrombotic thrombocytopenia following Ad26.COV2.S vaccine in a man presenting as acute venous thromboembolism.Am J Hematol. 2021 Sep 1;96(9):E346-E349. doi: 10.1002/ajh.26265. Epub 2021 Jun 17. Am J Hematol. 2021. PMID: 34096082 Free PMC article. No abstract available.
-
Thrombocytopenia and splanchnic thrombosis after Ad26.COV2.S vaccination successfully treated with transjugular intrahepatic portosystemic shunting and thrombectomy.Am J Hematol. 2021 Sep 1;96(9):1180-1182. doi: 10.1002/ajh.26258. Epub 2021 Jun 14. Am J Hematol. 2021. PMID: 34057234 Free PMC article. No abstract available.
-
Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination-United States, December 2020 to August 2021.Ann Intern Med. 2022 Apr;175(4):513-522. doi: 10.7326/M21-4502. Epub 2022 Jan 18. Ann Intern Med. 2022. PMID: 35038274 Free PMC article.
-
Adverse rare events to vaccines for COVID-19: From hypersensitivity reactions to thrombosis and thrombocytopenia.Int Rev Immunol. 2022;41(4):438-447. doi: 10.1080/08830185.2021.1939696. Epub 2021 Jul 12. Int Rev Immunol. 2022. PMID: 34251972 Free PMC article. Review.
-
COVID-19 Vaccines and Thrombosis-Roadblock or Dead-End Street?Biomolecules. 2021 Jul 13;11(7):1020. doi: 10.3390/biom11071020. Biomolecules. 2021. PMID: 34356644 Free PMC article. Review.
Cited by
-
Bridging gene therapy and next-generation vaccine technologies.Gene Ther. 2024 Nov 18. doi: 10.1038/s41434-024-00502-9. Online ahead of print. Gene Ther. 2024. PMID: 39558149 Review. No abstract available.
-
A SONAR report on Nirmatrelvir/ritonavir-associated rebound COVID-19: Using new databases for evaluating new diseases.PLoS One. 2024 Sep 25;19(9):e0308205. doi: 10.1371/journal.pone.0308205. eCollection 2024. PLoS One. 2024. PMID: 39321181 Free PMC article.
-
Cardiac and Neurological Complications Post COVID-19 Vaccination: A Systematic Review of Case Reports and Case Series.Vaccines (Basel). 2024 May 24;12(6):575. doi: 10.3390/vaccines12060575. Vaccines (Basel). 2024. PMID: 38932303 Free PMC article. Review.
-
The Immune System-A Double-Edged Sword for Adenovirus-Based Therapies.Viruses. 2024 Jun 17;16(6):973. doi: 10.3390/v16060973. Viruses. 2024. PMID: 38932265 Free PMC article. Review.
-
Neurovascular Adverse Effects of Sars-Cov-2 Vaccination.Drug Des Devel Ther. 2024 May 30;18:1891-1905. doi: 10.2147/DDDT.S464394. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 38836116 Free PMC article. Review.
References
-
- Greinacher A, Selleng K, Warkentin TE. Autoimmune heparin-induced thrombocytopenia. J Thromb Haemost 2017;15:2099-2114. - PubMed
-
- Warkentin TE. High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review. Expert Rev Hematol 2019;12:685-698. - PubMed
-
- Zhang R, Hefter Y. FDA review of efficacy and safety of the Janssen COVID-19 vaccine emergency use authorization request, February 26, 2021. (https://www.fda.gov/media/146267/download).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical